Given that genetic alterations in the MAPK and PI3K/AKT pathways are significant drivers of their activation [133, 134], it would be valuable to observe how ROS interacts with these genetic modifications to facilitate the initiation and progression of thyroid cancer. This evidence concerns the gene AKT1 and thyroid cancer.